Description

Introducing Gedopan-DSR: Extended Relief for Comprehensive Digestive Health

Dual-Action Formula: Gedopan-DSR tablets combine Pantoprazole (40mg), a potent proton pump inhibitor (PPI), with Domperidone (30mg) in a sustained-release formulation. This combination effectively controls gastric acid production and enhances gastric motility, providing sustained relief from acid reflux and associated symptoms.
Extended Symptom Relief: Pantoprazole maintains prolonged acid suppression to alleviate heartburn and acid regurgitation, while Domperidone in a sustained-release form ensures prolonged improvement in gastric emptying and discomfort, offering comprehensive symptom management throughout the day.
Convenient Dosage: Gedopan-DSR simplifies dosing with its once-daily sustained-release formulation, enhancing patient compliance and treatment efficacy.
Clinically Proven: Supported by clinical studies, Gedopan-DSR demonstrates robust efficacy in managing acid-related disorders and promoting digestive comfort, providing reassurance to healthcare providers and patients alike.
Pharmaceutical Excellence: Manufactured to stringent quality standards, Gedopan-DSR tablets ensure pharmaceutical integrity, delivering reliable safety, efficacy, and sustained relief in digestive health management.